Drugs Online |
 |
 | ||
|
RALISTA Evista |
|
| ||
Drugs Online » Prescription Drugs 14 » RALISTA Evista Raloxifene is used for: Treating and preventing osteoporosis (bone thinning) in women past menopause. Ralista is prescribed to treat and prevent osteoporosis the brittle-bone disease that strikes some women after menopause. A variety of factors promote osteoporosis. The more factors that apply to you the greater your chances of developing the disease. These factors include:Caucasian or Asian descentSlender buildEarly menopauseSmokingDrinkingA diet low in calciumAn inactive lifestyleOsteoporosis in the familyRaloxifene affects the cycle of bone formation and breakdown in the body and reduces loss of bone tissue. Raloxifene is used to treat or prevent osteoporosis in postmenopausal women. Raloxifene is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer. Buy RALISTA Evista and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About RALISTA Evista: Product Type: Prescription Drugs 14 RALISTA ( Evista Generic Raloxifene ) RALISTA (Evista Generic Raloxifene) Evista Generic Raloxifene 60mg Evista Generic Raloxifene RALISTA
View more Prescription Drugs 14 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
